ARICH ENTERPRISE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.9 TWD | -.--% |
|
+2.10% | -0.23% |
| Sales 2022 | 1.02B 31.27M 2.49B | Sales 2023 | 1.14B 35.02M 2.79B | Capitalization | 1.64B 50.29M 4.01B |
|---|---|---|---|---|---|
| Net income 2022 | 62M 1.9M 152M | Net income 2023 | 76M 2.33M 186M | EV / Sales 2022 | 0.8 x |
| Net cash position 2022 | 626M 19.24M 1.53B | Net cash position 2023 | 226M 6.94M 553M | EV / Sales 2023 | 1.24 x |
| P/E ratio 2022 |
23
x | P/E ratio 2023 |
21.5
x | Employees | 198 |
| Yield 2022 |
3.36% | Yield 2023 |
4.19% | Free-Float | 53.9% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +2.10% | ||
| Current month | -4.16% | ||
| 1 month | -4.16% | ||
| 3 months | +1.15% | ||
| 6 months | -0.68% | ||
| Current year | -0.23% |
1 week
21.50
22.00
1 month
21.4023.10
Current year
21.2023.10
1 year
20.0026.55
3 years
16.3031.45
5 years
15.0031.45
10 years
15.0048.80
| Managers | Title | Age | Since |
|---|---|---|---|
Shih Wei Biao
CEO | Chief Executive Officer | - | 30/06/21 |
Yi Wen Lin
DFI | Director of Finance/CFO | - | 30/06/21 |
| Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hui Tung Fu
CHM | Chairman | - | 03/06/09 |
Ming Ting Wang
IRO | Public Communications Contact | - | 03/06/09 |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 21.9 | -.--% | 65,743 |
| 29/04/24 | 21.9 | +1.15% | 107,918 |
| 26/04/24 | 21.65 | -.--% | 48,249 |
| 25/04/24 | 21.65 | -0.46% | 104,258 |
| 24/04/24 | 21.75 | -0.23% | 87,134 |
End-of-day quote Taipei Exchange, April 29, 2024
More quotes
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -0.23% | 50.08M | |
| +14.71% | 70.59B | |
| +1.36% | 25.06B | |
| +7.11% | 8.2B | |
| -20.55% | 7.96B | |
| -4.84% | 7.92B | |
| +3.91% | 4.71B | |
| +17.12% | 4.32B | |
| -1.24% | 4.01B | |
| -3.44% | 3.82B |
- Stock Market
- Equities
- 4173 Stock
